Association between GSTP1 CpG methylation and the early phase of lead exposure

References

• Alatise OI, Schrauzer GN. (2010). Lead exposure: a contributing cause of the current breast cancer epidemic in Nigerian women. Biol Trace Elem Res 136:127–39
   PubMed Web of Science ®Google Scholar
• Ballestar E, Paz MF, Valle L, et al. (2003). Methyl-CpG binding proteins identify novel sites of epigenetic inactivation in human cancer. EMBO J 22:6335–45
   PubMed Web of Science ®Google Scholar
• Bolin CM, Basha R, Cox D, et al. (2006). Exposure to lead and the developmental origin of oxidative DNA damage in the aging brain. FASEB J 20:788–90
   PubMed Web of Science ®Google Scholar
• Enokida H, Shiina H, Urakami S, et al. (2005). Ethnic group-related differences in CpG hypermethylation of the GSTP1 gene promoter among African-American, Caucasian and Asian patients with prostate cancer. Int J Cancer 116:174–81
   PubMed Web of Science ®Google Scholar
• Esteller M, Corn PG, Baylin SB, Herman JG. (2001). A gene hypermethylation profile of human cancer. Cancer Res 61:3225–9
   PubMed Web of Science ®Google Scholar
• Gonzalgo ML, Nakayama M, Lee SM, et al. (2004). Detection of GSTP1 methylation in prostatic secretions using combinatorial MSP analysis. Urology 63:414–18
   PubMed Web of Science ®Google Scholar
• Goyer RA. (1993). Lead toxicity: current concerns. Environ Health Perspect 100:177–87
   PubMed Web of Science ®Google Scholar
• Haleagrahara N, Jackie T, Chakravarthi S, et al. (2010). Protective effect of Etlingera elatior (torch ginger) extract on lead acetate – induced hepatotoxicity in rats. J Toxicol Sci 35:663–71
   PubMed Web of Science ®Google Scholar
• Herman JG, Baylin SB. (2003). Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 349:2042–54
   PubMed Web of Science ®Google Scholar
• IACR. (2006). Inorganic and organic lead compounds. IARC Monogr Eval Carcinog Risks Hum 87:1–471
   PubMedGoogle Scholar
• Jones PA, Baylin SB. (2002). The fundamental role of epigenetic events in cancer. Nat Rev Genet 3:415–28
   PubMed Web of Science ®Google Scholar
• Kovatsi L, Georgiou E, Ioannou A, et al. (2010). p16 promoter methylation in Pb2+-exposed individuals. Clin Toxicol (Phila) 48:124–8
   PubMed Web of Science ®Google Scholar
• Lasabova Z, Tilandyova P, Kajo K, et al. (2010). Hypermethylation of the GSTP1 promoter region in breast cancer is associated with prognostic clinicopathological parameters. Neoplasma 57:35–40
   PubMedGoogle Scholar
• Li C, Xu M, Wang S, et al. (2011). Lead exposure suppressed ALAD transcription by increasing methylation level of the promoter CpG islands. Toxicol Lett 203:48–53
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402–8
   PubMed Web of Science ®Google Scholar
• Meiers I. (2010). Glutathione S-TRansferase pi (GSTP1). Atlas Genet Cytogenet Oncol Haematol 14:1184–9
   Google Scholar
• Patrick L. (2006). Lead toxicity part II: the role of free radical damage and the use of antioxidants in the pathology and treatment of lead toxicity. Alternat Med Rev 11:114–27
   PubMed Web of Science ®Google Scholar
• Pilsner JR, Hu H, Ettinger A, et al. (2009). Influence of prenatal lead exposure on genomic methylation of cord blood DNA. Environ Health Perspect 117:1466–71
   PubMed Web of Science ®Google Scholar
• Rajaraman P, Stewart PA, Samet JM, et al. (2006). Lead, genetic susceptibility, and risk of adult brain tumors. Cancer Epidemiol Biomarkers Prev 15:2514–20
   PubMed Web of Science ®Google Scholar
• Ronneberg JA, Tost J, Solvang HK, et al. (2008). GSTP1 promoter haplotypes affect DNA methylation levels and promoter activity in breast carcinomas. Cancer Res 68:5562–71
   PubMed Web of Science ®Google Scholar
• Sivonova M, Waczulikova I, Dobrota D, et al. (2009). Polymorphisms of glutathione-S-transferase M1, T1, P1 and the risk of prostate cancer: a case-control study. J Exp Clin Cancer Res 28:32
   PubMed Web of Science ®Google Scholar
• Steenland K, Boffetta P. (2000). Lead and cancer in humans: where are we now? Am J Ind Med 38:295–9
   PubMed Web of Science ®Google Scholar
• Suzuki T, Morimura S, Diccianni MB, et al. (1996). Activation of glutathione transferase P gene by lead requires glutathione transferase P enhancer I. J Biol Chem 271:1626–32
   PubMedGoogle Scholar
• van Wijngaarden E, Dosemeci M. (2006). Brain cancer mortality and potential occupational exposure to lead: findings from the National Longitudinal Mortality Study, 1979–1989. Int J Cancer 119:1136–44
   PubMed Web of Science ®Google Scholar
• Witzmann FA, Daggett DA, Fultz CD, et al. (1998). Glutathione S-transferases: two-dimensional electrophoretic protein markers of lead exposure. Electrophoresis 19:1332–5
   PubMedGoogle Scholar
• Wright LS, Kornguth SE, Oberley TD, Siegel FL. (1998). Effects of lead on glutathione S-transferase expression in rat kidney: a dose-response study. Toxicol Sci 46:254–9
   PubMed Web of Science ®Google Scholar
• Wright RO, Schwartz J, Wright RJ, et al. (2010). Biomarkers of lead exposure and DNA methylation within retrotransposons. Environ Health Perspect 118:790–5
   PubMed Web of Science ®Google Scholar